Home

Inspire Medical Systems, Inc. Common Stock (INSP)

89.87
+6.60 (7.93%)
NYSE · Last Trade: Nov 21st, 11:16 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close83.27
Open83.50
Bid90.40
Ask94.68
Day's Range83.37 - 90.57
52 Week Range70.77 - 216.01
Volume1,391,655
Market Cap2.45B
PE Ratio (TTM)65.60
EPS (TTM)1.4
Dividend & YieldN/A (N/A)
1 Month Average Volume1,245,647

Chart

About Inspire Medical Systems, Inc. Common Stock (INSP)

Inspire Medical Systems is a medical device company focused on developing innovative solutions to treat obstructive sleep apnea. The company specializes in the design and manufacturing of implantable neurostimulation devices that work to improve airflow during sleep by stimulating the hypoglossal nerve, which helps keep the airway open. Their technology aims to provide an effective alternative for individuals who are unable to tolerate traditional continuous positive airway pressure (CPAP) therapy. Through its pioneering approach, Inspire Medical Systems is committed to enhancing the quality of life for patients with sleep-disordered breathing conditions. Read More

News & Press Releases

Align Technology, Tandem Diabetes, Integra LifeSciences, Lantheus, and Inspire Medical Systems Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a further adjustment” in the near term, sparking a significant market rally. Following his remarks, the probability of the central bank cutting rates at its December meeting jumped from 39% to over 73%, according to the CME FedWatch tool. This positive sentiment provided relief to markets amid concerns over high valuations, particularly in AI-related stocks.
Via StockStory · November 21, 2025
Levi & Korsinsky Reminds Inspire Medical Systems, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of January 5, 2026 - INSP
NEW YORK - November 21, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Inspire Medical Systems, Inc. (NYSE: INSP) of a class action securities lawsuit.
Via TheNewswire.com · November 21, 2025
Levi & Korsinsky Reminds Inspire Medical Systems, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of January 5, 2026 - INSP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · November 21, 2025
INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, Nov. 21, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inspire Medical Systems, Inc. (“Inspire” or “the Company”) (NYSE: INSP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · November 21, 2025
Bragar Eagel & Squire, P.C. Reminds Investors of Stride, Firefly, Six Flags, and Inspire Medical To Contact the Firm Regarding Class Action Deadlines
NEW YORK, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Stride, Inc. (NYSE:LRN), Firefly Aerospace Inc. (NASDAQ:FLY), Six Flags Entertainment Corporation (NYSE:FUN), and Inspire Medical Systems, Inc. (NYSE:INSP). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · November 20, 2025
INSP INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their Options
By Faruqi & Faruqi LLP · Via GlobeNewswire · November 20, 2025
Shareholders of Inspire Medical Systems, Inc. Should Contact Levi & Korsinsky Before January 5, 2026 to Discuss Your Rights - INSP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · November 20, 2025
Shareholders of Inspire Medical Systems, Inc. Should Contact Levi & Korsinsky Before January 5, 2026 to Discuss Your Rights - INSP
NEW YORK - November 20, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Inspire Medical Systems, Inc. (NYSE: INSP) of a class action securities lawsuit.
Via TheNewswire.com · November 20, 2025
1 Safe-and-Steady Stock to Own for Decades and 2 We Question
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
Via StockStory · November 20, 2025
Levi & Korsinsky Reminds Inspire Medical Systems, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of January 5, 2026 - INSP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · November 19, 2025
Levi & Korsinsky Reminds Inspire Medical Systems, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of January 5, 2026 - INSP
NEW YORK - November 19, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Inspire Medical Systems, Inc. (NYSE: INSP) of a class action securities lawsuit.
Via TheNewswire.com · November 19, 2025
INSP ALERT: Kirby McInerney LLP Reminds Inspire Medical Systems, Inc. Investors of Important Deadline in Class Action Lawsuit
If you have suffered a loss on your Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE:INSP) investment, contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
By Kirby McInerney LLP · Via Business Wire · November 18, 2025
January 5, 2026 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against INSP
NEW YORK - November 18, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Inspire Medical Systems, Inc. (NYSE: INSP) of a class action securities lawsuit.
Via TheNewswire.com · November 18, 2025
January 5, 2026 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against INSP
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · November 18, 2025
Inspire Medical Systems, Inc. Stockholders with Large Losses Should Contact Robbins LLP for Information About Leading the INSP Securities Class Action
SAN DIEGO, Nov. 18, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · November 18, 2025
Deadline Alert: Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Glancy Prongay & Murray LLP reminds investors of the upcoming January 5, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”).
By Glancy Prongay & Murray LLP · Via Business Wire · November 18, 2025
INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inspire Medical Systems, Inc. (“Inspire” or “the Company”) (NYSE: INSP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · November 18, 2025
Deadline Approaching: Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
Law Offices of Howard G. Smith reminds investors of the upcoming January 5, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”).
By Law Offices of Howard G. Smith · Via Business Wire · November 17, 2025
Class Action Filed Against Inspire Medical Systems, Inc. (INSP) Seeking Recovery for Investors - Contact Levi & Korsinsky
NEW YORK - November 17, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Inspire Medical Systems, Inc. (NYSE: INSP) of a class action securities lawsuit.
Via TheNewswire.com · November 17, 2025
Class Action Filed Against Inspire Medical Systems, Inc. (INSP) Seeking Recovery for Investors - Contact Levi & Korsinsky
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · November 17, 2025
Law Offices of Frank R. Cruz Encourages Inspire Medical Systems, Inc. (INSP) Shareholders to Inquire About Securities Fraud Class Action
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”). Inspire investors have until January 5, 2026 to file a lead plaintiff motion.
By The Law Offices of Frank R. Cruz · Via Business Wire · November 14, 2025
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Inspire Medical Systems, Inc. (INSP) Shareholders To Inquire About Securities Fraud Class Action
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”). Inspire investors have until January 5, 2026 to file a lead plaintiff motion.
By Glancy Prongay & Murray LLP · Via Business Wire · November 14, 2025
Law Offices of Howard G. Smith Encourages Inspire Medical Systems, Inc. (INSP) Shareholders To Inquire About Securities Fraud Class Action
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, inclusive (the “Class Period”). Inspire investors have until January 5, 2026 to file a lead plaintiff motion.
By Law Offices of Howard G. Smith · Via Business Wire · November 13, 2025
INSP Investors Have Opportunity to Lead Inspire Medical Systems, Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, Nov. 13, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inspire Medical Systems, Inc. (“Inspire” or “the Company”) (NYSE: INSP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall Law · Via GlobeNewswire · November 13, 2025
Inspire Medical Systems, Inc. (INSP) Faces Investor Suit Over Disastrous Inspire V Launch-- Hagens Berman
Inspire Medical Systems, Inc. (NYSE: INSP) is now grappling with a proposed class-action lawsuit alleging the company misled investors about the commercial readiness and demand for its critical “next generation” sleep apnea device, the Inspire V. The litigation zeroes in on the disparity between the company's confident assurances and the subsequent disastrous rollout that led to a dramatic stock crash.
By Hagens Berman · Via Business Wire · November 13, 2025